519 related articles for article (PubMed ID: 33529167)
1. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
Bolouri H; Speake C; Skibinski D; Long SA; Hocking AM; Campbell DJ; Hamerman JA; Malhotra U; Buckner JH;
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529167
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
[TBL] [Abstract][Full Text] [Related]
3. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Borges RC; Hohmann MS; Borghi SM
Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
[TBL] [Abstract][Full Text] [Related]
5. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
6. The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19.
Xu G; Qi F; Wang H; Liu Y; Wang X; Zou R; Yuan J; Liao X; Liu Y; Zhang S; Zhang Z
Front Immunol; 2021; 12():816745. PubMed ID: 35095917
[TBL] [Abstract][Full Text] [Related]
7. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
Rendeiro AF; Casano J; Vorkas CK; Singh H; Morales A; DeSimone RA; Ellsworth GB; Soave R; Kapadia SN; Saito K; Brown CD; Hsu J; Kyriakides C; Chiu S; Cappelli LV; Cacciapuoti MT; Tam W; Galluzzi L; Simonson PD; Elemento O; Salvatore M; Inghirami G
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361110
[TBL] [Abstract][Full Text] [Related]
8. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
Koutsakos M; Rowntree LC; Hensen L; Chua BY; van de Sandt CE; Habel JR; Zhang W; Jia X; Kedzierski L; Ashhurst TM; Putri GH; Marsh-Wakefield F; Read MN; Edwards DN; Clemens EB; Wong CY; Mordant FL; Juno JA; Amanat F; Audsley J; Holmes NE; Gordon CL; Smibert OC; Trubiano JA; Hughes CM; Catton M; Denholm JT; Tong SYC; Doolan DL; Kotsimbos TC; Jackson DC; Krammer F; Godfrey DI; Chung AW; King NJC; Lewin SR; Wheatley AK; Kent SJ; Subbarao K; McMahon J; Thevarajan I; Nguyen THO; Cheng AC; Kedzierska K
Cell Rep Med; 2021 Mar; 2(3):100208. PubMed ID: 33564749
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
Purbey PK; Roy K; Gupta S; Paul MK
Mol Immunol; 2023 Apr; 156():111-126. PubMed ID: 36921486
[TBL] [Abstract][Full Text] [Related]
10. Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients.
Zulu MZ; Sureshchandra S; Pinski AN; Doratt B; Shen W; Messaoudi I
Front Immunol; 2021; 12():760288. PubMed ID: 34707619
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of the immunological landscape of COVID-19 patients based on sex and disease severity by multi-omics analysis.
Zhang T; Abdelrahman Z; Liu Q; Wang X; Chen Z
Chem Biol Interact; 2022 Jan; 352():109777. PubMed ID: 34896122
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
13. Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality.
Gygi JP; Maguire C; Patel RK; Shinde P; Konstorum A; Shannon CP; Xu L; Hoch A; Jayavelu ND; Haddad EK; ; Reed EF; Kraft M; McComsey GA; Metcalf JP; Ozonoff A; Esserman D; Cairns CB; Rouphael N; Bosinger SE; Kim-Schulze S; Krammer F; Rosen LB; van Bakel H; Wilson M; Eckalbar WL; Maecker HT; Langelier CR; Steen H; Altman MC; Montgomery RR; Levy O; Melamed E; Pulendran B; Diray-Arce J; Smolen KK; Fragiadakis GK; Becker PM; Sekaly RP; Ehrlich LI; Fourati S; Peters B; Kleinstein SH; Guan L
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690733
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
Cells; 2021 May; 10(6):. PubMed ID: 34071149
[TBL] [Abstract][Full Text] [Related]
15. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
Front Immunol; 2021; 12():697622. PubMed ID: 34777333
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
17. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
18. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
Ruenjaiman V; Hirankarn N; Palaga T
Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
[TBL] [Abstract][Full Text] [Related]
20. The immunology and immunopathology of COVID-19.
Merad M; Blish CA; Sallusto F; Iwasaki A
Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
